Medical Research News

RSS

Silencing the TLR4 gene can prevent cardiovascular disease in diabetic patients

Silencing the TLR4 gene can stop the process which may lead to cardiovascular disease in diabetic patients. Researchers demonstrated that TLR4 plays a critical role in hyperglycaemic cardiac apoptosis, and that silencing the gene using specific small interfering RNA can prevent it.

10 Dec 2010

Older people living in racially segregated neighborhoods have higher chance of developing cancer: Study

Older people who live in racially segregated neighborhoods with high crime rates have a much higher chance of developing cancer than do older people with similar health histories and income levels who live in safer, less segregated neighborhoods.

10 Dec 2010

Some key molecular events in immune system contribute to inflammatory bowel disease: Scientists

Scientists at the Virginia Bioinformatics Institute at Virginia Tech have discovered some of the key molecular events in the immune system that contribute to inflammatory bowel disease. The results, which help researchers move one step further in their efforts to develop new drugs to treat inflammatory and immune-mediated diseases, are reported in the November 2010 edition of the journal Mucosal Immunology from the Nature Publishing Group.

10 Dec 2010

Researchers verify several factors associated with increased risk of brain metastases in breast cancer patients

Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement. One way to improve the affected patients' survival might be to prevent the brain metastases from arising in the first place. With that in mind, researchers have been working on a predictive model that accurately identifies these high risk patients.

10 Dec 2010

New three-drug combination may be effective for newly diagnosed blood cancer patients: Study

A new three-drug combination used to treat the blood cancer multiple myeloma may be effective as a front-line therapy for newly diagnosed patients, according to a study led by the University of Michigan Comprehensive Cancer Center.

9 Dec 2010

Warfarin may not be beneficial to some patients with atrial fibrillation: Researchers

Researchers at the University of Cincinnati and Massachusetts General Hospital have found that warfarin, a known anticoagulation (blood-thinning) drug, may not be as beneficial to some patients with atrial fibrillation as previously thought.

9 Dec 2010

Vibrio cholerae evolves two new mechanisms to cause similar disease

New clinical strains of cholera appear to have evolved a distinctly different mechanism to cause the same disease according to research published in the current issue of the online journal mBio-.

9 Dec 2010

Divorce: men get fitter women fatter!

Divorce is a stressful experience but according to a new study published in the American Journal of Epidemiology, it can do good to men’s fitness. Women, on the other hand, are likely to become less healthy.

9 Dec 2010

Ingenuity Systems and CLC bio collaborate to provide interoperability between software solutions

Today Ingenuity Systems and CLC bio announced that they're collaborating to provide interoperability between their software solutions. The aim of the partnership is to provide researchers with the ability to easily exchange data between CLC bio's enterprise and desktop solutions and Ingenuity's pathway analysis software (IPA®), in order to perform both array and next-generation sequencing data and knowledge analyses.

9 Dec 2010

Hamilton Thorne launches new Stiletto laser for regenerative medicine and stem cell research markets

Hamilton Thorne Ltd., a leading provider of advanced laser systems for the regenerative medicine and stem cell research markets, today announced the launch of its new Stiletto™ laser system. The Stiletto™ laser system has broad applications for research with a variety of cells, allowing the Company to enter new and exciting research markets, including developmental and advanced cell biology.

9 Dec 2010

Nacalai to distribute Techulon's Glycofect Transfection Reagent platform products in Japan

Techulon Inc., an early stage life sciences company has signed an agreement with Nacalai USA, Inc. and its parent company Nacalai Tesque, Inc. for distribution of its Glycofect Transfection Reagent platform products in Japan. Glycofect is a polymeric transfection reagent designed to be particularly effective in primary cells of therapeutic interest. It is being used by government, university and corporate laboratories around the world for advanced research towards better understanding of cell biology and for development of new cell-based therapeutics.

9 Dec 2010

Registered dietitians practice what they preach

When it comes to eating a balanced diet, taking vitamins or other dietary supplements, exercising regularly, and engaging in other wellness behaviors, registered dietitians come out on top among eight healthcare professional populations according to the "Life…supplemented" Healthcare Professionals (HCP) Impact Studies.

9 Dec 2010

Study to develop ways to track individual's exposure to traffic pollution

Researchers at King's College London are developing ways of working out a person's individual exposure to traffic pollution when travelling to, from, and around London.

9 Dec 2010

Childhood maltreatment more strongly associated with current psychiatric symptoms than military sexual stressors

A study of long-term, active duty military personnel who used Department of Veterans Affairs' health services showed that childhood maltreatment and other high magnitude stressors, such as being in a serious accident or a natural disaster, were more strongly associated with participants' current psychiatric symptoms than were their military sexual experiences, such as sexual harassment.

9 Dec 2010

Ameco Medical to commence clinical trials for PNT procedure's reimbursement approval

Sunridge International, announced today that Ameco Medical is preparing to start the short term clinical trials needed for reimbursement approval.

9 Dec 2010

New finding could help identify individuals with abnormal brain function

Mayo Clinic researchers found that the part of the brain generating seizures in individuals with epilepsy is functionally isolated from surrounding brain regions. The researchers hope this finding could be a clinical biomarker to help identify individuals with abnormal brain function.

9 Dec 2010

Results of proteomics study performed utilizing plasma samples from ADNI now available

The Foundation for the National Institutes of Health's Biomarkers Consortium announced today that the results of a proteomics study performed utilizing plasma samples from the Alzheimer's Disease Neuroimaging Initiative are ready to be shared with scientists worldwide for further analysis.

9 Dec 2010

New study shows how meditators don't ponder pain

Zen meditation has many health benefits, including a reduced sensitivity to pain. According to new research from the Universit- de Montr-al, meditators do feel pain but they simply don't dwell on it as much. These findings, published in the month's issue of Pain, may have implications for chronic pain sufferers, such as those with arthritis, back pain or cancer.

9 Dec 2010

Study shows living in walkable neighborhood enhances individual's quality of life

People who live in walkable communities are more civically involved and have greater levels of trust than those who live in less walkable neighborhoods. And this increase in so-called 'social capital' is associated with higher quality of life, according to Shannon Rogers and her team from the University of New Hampshire in the US. Their research, looking at the social benefits of walkability in communities, is published online in Springer's journal Applied Research in Quality of Life.

9 Dec 2010

Weifang Shengtai holds unveiling ceremony for 'Joint University-Business Community Program' with HUT

Shengtai Pharmaceutical, Inc. announced today that Weifang Shengtai Pharmaceutical, the Company's subsidiary in Changle, Shandong, China ("the Shandong Subsidiary"), held an unveiling ceremony for the "Joint University-Business Community Program" between the Company's Shandong subsidiary and the Hubei University of Technology ("HUT") in Changle, Shandong, China on December 4, 2010.

9 Dec 2010

Medical Research News

Silencing the TLR4 gene can prevent cardiovascular disease in diabetic patients

Older people living in racially segregated neighborhoods have higher chance of developing cancer: Study

Some key molecular events in immune system contribute to inflammatory bowel disease: Scientists

Researchers verify several factors associated with increased risk of brain metastases in breast cancer patients

New three-drug combination may be effective for newly diagnosed blood cancer patients: Study

Warfarin may not be beneficial to some patients with atrial fibrillation: Researchers

Vibrio cholerae evolves two new mechanisms to cause similar disease

Divorce: men get fitter women fatter!

Ingenuity Systems and CLC bio collaborate to provide interoperability between software solutions

Hamilton Thorne launches new Stiletto laser for regenerative medicine and stem cell research markets

Nacalai to distribute Techulon's Glycofect Transfection Reagent platform products in Japan

Registered dietitians practice what they preach

Study to develop ways to track individual's exposure to traffic pollution

Childhood maltreatment more strongly associated with current psychiatric symptoms than military sexual stressors

Ameco Medical to commence clinical trials for PNT procedure's reimbursement approval

New finding could help identify individuals with abnormal brain function

Results of proteomics study performed utilizing plasma samples from ADNI now available

New study shows how meditators don't ponder pain

Study shows living in walkable neighborhood enhances individual's quality of life

Weifang Shengtai holds unveiling ceremony for 'Joint University-Business Community Program' with HUT

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News